BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8838267)

  • 21. [Treatment of non-small-cell bronchial cancers].
    Ayoub A; Kammoun S
    Tunis Med; 1998 Mar; 76(3):1-8. PubMed ID: 9844524
    [No Abstract]   [Full Text] [Related]  

  • 22. [Concurrent radiotherapy and chemotherapy for non-small-cell lung cancer--continuous infusion of low dose cisplatin and 5-FU].
    Itoh Y; Fuwa N; Kikuchi Y; Matsumoto A; Muramoto H; Kato E; Shinoda M; Sugiura T
    Gan To Kagaku Ryoho; 1996 Oct; 23(12):1721-4. PubMed ID: 8886053
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical trials referral resource. Clinical trials in non-small-cell lung cancer.
    Saxman SB; Blatner GL; Cheson BD
    Oncology (Williston Park); 1999 Oct; 13(10):1384, 1387-8. PubMed ID: 10549565
    [No Abstract]   [Full Text] [Related]  

  • 24. Chemotherapy and radiotherapy in the treatment of resectable non-small-cell lung cancer.
    Bernstein ED; Herbert SM; Hanna NH
    Ann Surg Oncol; 2006 Mar; 13(3):291-301. PubMed ID: 16450219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Scalpels, beams, drugs, and dreams: challenges of stage IIIA-N2 non-small-cell lung cancer.
    Johnson DH; Rusch VW; Turrisi AT
    J Natl Cancer Inst; 2007 Mar; 99(6):415-8. PubMed ID: 17374824
    [No Abstract]   [Full Text] [Related]  

  • 26. Combined immunotherapy and chemotherapy with tuftsin plus cyclophosphamide in the treatment of non-small-cell carcinoma of the lung.
    Warner E; Sulkes A; Gez E; Uziely B; Ben-Baruch N; Ben-Yosef R; Biran S; Catane R
    Chemioterapia; 1987 Jun; 6(2 Suppl):706-8. PubMed ID: 2855624
    [No Abstract]   [Full Text] [Related]  

  • 27. Is double autologous stem-cell transplantation appropriate for new multiple myeloma patients?
    van Rhee F
    Nat Clin Pract Oncol; 2008 Feb; 5(2):70-1. PubMed ID: 17984985
    [No Abstract]   [Full Text] [Related]  

  • 28. Thalidomide and dexamethasone: a new standard of care for initial therapy in multiple myeloma.
    Richardson P; Anderson K
    J Clin Oncol; 2006 Jan; 24(3):334-6. PubMed ID: 16365174
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical trials referral resource.
    Cheson BD; Ungerleider RS
    Oncology (Williston Park); 1992 Nov; 6(11):30, 32, 34-6. PubMed ID: 1332740
    [No Abstract]   [Full Text] [Related]  

  • 30. Investigations of new drugs in combination with cisplatin in stage III non-small cell lung cancer.
    Vokes EE; Leopold KA; Herndon J; Green MR
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-42-S8-45. PubMed ID: 9207317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Multimodality therapy for small-cell lung cancer].
    Yokoyama A
    Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():405-11. PubMed ID: 9369915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined modality therapy for stage III non-small cell lung cancer.
    Stinchcombe TE; Fried D; Morris DE; Socinski MA
    Oncologist; 2006; 11(7):809-23. PubMed ID: 16880240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of lung cancer--state of the art in 2000].
    Nakanishi Y; Inoue K; Hara N
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1247-52. PubMed ID: 10945023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Management of non-small-cell lung cancer (NSCLC) in elderly patients].
    Westeel V
    Rev Pneumol Clin; 2004 Nov; 60(5 Pt 3):4S35-4S38. PubMed ID: 15687992
    [No Abstract]   [Full Text] [Related]  

  • 35. [Trial of combined radiotherapy and chemotherapy (CBDCA) for post-operative non-small cell lung cancer (N2)].
    Nakano N; Kishima H; Yamamura N; Ueda S; Kameda Y; Miyagawa M
    Gan To Kagaku Ryoho; 1999 May; 26(6):845-7. PubMed ID: 10410157
    [No Abstract]   [Full Text] [Related]  

  • 36. Will future progress in non-small-cell lung cancer be step by step... or by leaps and bounds?
    Movsas B
    J Clin Oncol; 2005 Sep; 23(25):5859-61. PubMed ID: 16087952
    [No Abstract]   [Full Text] [Related]  

  • 37. Neoadjuvant chemotherapy in early-stage non-small cell lung cancer.
    Edelman MJ
    Expert Rev Anticancer Ther; 2001 Aug; 1(2):229-35. PubMed ID: 12113028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003.
    Pfister DG; Johnson DH; Azzoli CG; Sause W; Smith TJ; Baker S; Olak J; Stover D; Strawn JR; Turrisi AT; Somerfield MR;
    J Clin Oncol; 2004 Jan; 22(2):330-53. PubMed ID: 14691125
    [No Abstract]   [Full Text] [Related]  

  • 39. Increasing chemotherapy dose density and intensity: phase I trials in non-small cell lung cancer and non-Hodgkin's lymphoma.
    Blayney DW; McGuire BW; Cruickshank SE; Johnson DH
    Oncologist; 2005 Feb; 10(2):138-49. PubMed ID: 15709216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term remission of paraprotein-induced immunotactoid glomerulopathy after high-dose therapy and autologous blood stem cell transplantation.
    Witzens-Harig M; Waldherr R; Beimler J; Zeier M; Hansmann J; Ho AD; Goldschmidt H; Moehler T
    Ann Hematol; 2007 Dec; 86(12):927-30. PubMed ID: 17605010
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.